Net margin is the percentage of revenue a company keeps as profit after every expense and tax. It is net income divided by revenue, and the table shows both amounts beside the percentage. A higher net margin means more of each sales dollar reaches the bottom line. One-time gains, write-downs and tax items pass through net income, so a single period's net margin can move for reasons unrelated to the underlying business. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.
Dianthus Therapeutics, Inc. /DE/ net margin for the quarter ending 2025-12-31 was -22687.32%, a change of -20542.53% year-over-year.
Dianthus Therapeutics, Inc. /DE/ net margin for the quarter ending 2025-09-30 was -9284.09%, a change of -8125.07% year-over-year.
Dianthus Therapeutics, Inc. /DE/ net margin for the quarter ending 2025-06-30 was -16388.08%, a change of -15442.99% year-over-year.
Dianthus Therapeutics, Inc. /DE/ net margin for the quarter ending 2025-03-31 was -2537.49%, a change of -964.49% year-over-year.
Dianthus Therapeutics, Inc. /DE/ net margin for fiscal 2025 was -7973.33%, a change of -6610.56% from fiscal 2024.
Dianthus Therapeutics, Inc. /DE/ net margin for fiscal 2024 was -1362.77%, a change of 178.45% from fiscal 2023.
Dianthus Therapeutics, Inc. /DE/ net margin for fiscal 2023 was -1541.22%.